Skip to content
10-K

Annual Report

ZYNERBA PHARMACEUTICALS, INC.

0001558370-23-004765

← back to feed
Filed
Mar 28, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 22, 2023 53.35M sh
Shares Diluted FY 2022 · Dec 31, 2022 42.66M sh
Shares Diluted FY 2022 · Dec 31, 2021 39.26M sh
Shares Diluted FY 2022 · Dec 31, 2020 27.02M sh
Capex FY 2022 · Dec 31, 2022 $154.11K
Capex FY 2022 · Dec 31, 2021 $47.57K
Capex FY 2022 · Dec 31, 2020 $445.31K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$23.03M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$33.46M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$41.31M
Cash And Equivalents FY 2022 · Dec 31, 2022 $50.64M
Cash And Equivalents FY 2022 · Dec 31, 2021 $67.81M
Stockholders Equity FY 2022 · Dec 31, 2022 $46.23M
Stockholders Equity FY 2022 · Dec 31, 2021 $70.91M
Stockholders Equity FY 2022 · Dec 31, 2020 $60.14M
Stockholders Equity FY 2022 · Dec 31, 2019 $75.6M
Current Liabilities FY 2022 · Dec 31, 2022 $9.17M
Current Liabilities FY 2022 · Dec 31, 2021 $9.9M
Total Liabilities FY 2022 · Dec 31, 2022 $9.29M
Total Liabilities FY 2022 · Dec 31, 2021 $10.26M
Current Assets FY 2022 · Dec 31, 2022 $54.78M
Current Assets FY 2022 · Dec 31, 2021 $80.22M
Total Assets FY 2022 · Dec 31, 2022 $55.52M
Total Assets FY 2022 · Dec 31, 2021 $81.17M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.82
Eps Diluted FY 2022 · Dec 31, 2021 −$0.95
Eps Diluted FY 2022 · Dec 31, 2020 −$1.90
Eps Basic FY 2022 · Dec 31, 2022 −$0.82
Eps Basic FY 2022 · Dec 31, 2021 −$0.95
Eps Basic FY 2022 · Dec 31, 2020 −$1.90
Sga Expense FY 2022 · Dec 31, 2022 $14.15M
Sga Expense FY 2022 · Dec 31, 2021 $15.35M
Sga Expense FY 2022 · Dec 31, 2020 $16.41M
Rd Expense FY 2022 · Dec 31, 2022 $21.1M
Rd Expense FY 2022 · Dec 31, 2021 $21.42M
Rd Expense FY 2022 · Dec 31, 2020 $35.65M
Net Income FY 2022 · Dec 31, 2022 −$35.04M
Net Income FY 2022 · Dec 31, 2021 −$37.31M
Net Income FY 2022 · Dec 31, 2020 −$51.34M
Operating Income FY 2022 · Dec 31, 2022 −$35.25M
Operating Income FY 2022 · Dec 31, 2021 −$36.77M
Operating Income FY 2022 · Dec 31, 2020 −$52.06M